J9181 Etoposide injection
Also known as: etoposide, VePesid
Intravenous injection of etoposide, a semisynthetic epipodophyllotoxin topoisomerase II inhibitor.
In Plain Language
DNA-damaging chemotherapy; testicular and lung cancer drug
Clinical Context
Used for testicular cancer, small cell lung cancer, and lymphomas as component of combination regimens.
RVU Information
CPT J9181 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9181?
CPT J9181 (Etoposide injection) is a J Codes (Drugs) code. Intravenous injection of etoposide, a semisynthetic epipodophyllotoxin topoisomerase II inhibitor.
How is J9181 administered?
CPT J9181 is administered by a healthcare provider, typically via injection or infusion. Used for testicular cancer, small cell lung cancer, and lymphomas as component of combination regimens. It is used by Oncology, Medical Oncology.
When is CPT J9181 used?
Used for testicular cancer, small cell lung cancer, and lymphomas as component of combination regimens.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.